After-Hours Movers 12/10: (ASPU) (OLLI) (PLAY) Higher; (ITRM) (GME) (AQST) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Aspen Group, Inc. (ASPU) Announces Proposed Common Share Offering
December 12, 2019 4:02 PM ESTAspen Group, Inc. (NASDAQ: ASPU) today announced that... More
Momenta Phama (MNTA) Prices 14.516M Share Common Offering at $15.50/Sh
December 12, 2019 8:03 AM ESTMomenta Pharmaceuticals, Inc. (NASDAQ: MNTA) today announced the pricing of its underwritten public offering of 14,516,130 shares of its common stock at the public offering price of $15.50 per share for total gross proceeds to Momenta of approximately $225.0 million. Momenta has granted the underwriters an option... More
Marinus Pharma (MRNS) Announces Elan Ezickson to Board
December 12, 2019 7:31 AM ESTMarinus Pharmaceuticals, Inc. (NASDAQ: MRNS) announced today that Elan Ezickson, has joined the Companys Board of Directors. Mr. Ezickson is a highly accomplished executive with over 30 years of experience in the life sciences industry across commercial, operational and strategic... More
Marinus Pharma (MRNS) Prices 28M Share Common Offering at $1.25/Sh; Announces Concurrent Private Placement
December 11, 2019 9:15 AM ESTMarinus Pharmaceuticals, Inc. (NASDAQ: MRNS) today announced the pricing of an underwritten public offering of 28,000,000 shares of common stock at a public offering price of $1.25 per share. The gross proceeds to the Company from the public offering and concurrent private placement are expected to be approximately $65 million before deducting underwriting discounts and commissions, placement agent fees, and other estimated offering expenses. The Company has granted to the underwriters... More
Rocket Pharmaceuticals (RCKT) Prices 3.82M Share Common Offering at $22.25/Sh
December 11, 2019 5:59 AM ESTRocket Pharmaceuticals, Inc. (NASDAQ:... More
